Kwang Young Lee
Inventor
Stats
- 4 US patents issued
- 8 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 4 US Patents Issued
- 8 US Applications Filed
- 23 Total Citation Count
- Jan 25, 2022 Most Recent Filing
- Jun 21, 1999 Earliest Filing
Work History
| Patent Owner | Applications Filed | Year |
|---|---|---|
| SAMSUNG ELECTRO-MECHANICS CO., LTD. | 1
| 1999
|
| LG ELECTRONICS INC. | 6
| 2007
|
Inventor Addresses
| Address | Duration |
|---|---|
| Changwon-si, KR | Feb 07, 08 - Apr 17, 12 |
| Gwangyang-si, Jeollanam-do, KR | Apr 10, 25 - Apr 10, 25 |
| Gyeonggi-do, KR | Aug 08, 19 - May 27, 21 |
| Kyungki-do, KR | Apr 17, 01 - Apr 17, 01 |
| Yongin-si, KR | Feb 02, 23 - Feb 02, 23 |
Technology Profile
| Technology | Matters | |
|---|---|---|
| A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 3 |
| A61P: | THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS | 2 |
| B41J: | TYPEWRITERS; SELECTIVE PRINTING MECHANISMS, i.e. MECHANISMS PRINTING OTHERWISE THAN FROM A FORME; CORRECTION OF TYPOGRAPHICAL ERRORS | 1 |
Patents / Publication
| Patents / Publication # | Year of Publication / Issued | Title | Citations |
|---|---|---|---|
| 2025/0116,797 | 2025 | METHOD FOR PREPARING ESTER THIOL COMPOUND AND OPTICAL RESIN CONTAINING THE SAME | 0 |
| 2023/0033,410 | 2023 | COMPLEX FORMULATION COMPRISING SITAGLIPTIN AND DAPAGLIFLOZIN, AND PREPARATION METHOD THEREFOR | 0 |
| 2021/0154,180 | 2021 | FORMULATION HAVING IMPROVED PH-DEPENDENT DRUG-RELEASE CHARACTERISTICS CONTAINING ESOMEPRAZOLE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF | 0 |
| 10946003 | 2021 | Formulation having improved pH-dependent drug-release characteristics, containing esomeprazole or pharmaceutically acceptable salt thereof | 0 |
| 2019/0240,209 | 2019 | FORMULATION HAVING IMPROVED PH-DEPENDENT DRUG- RELEASE CHARACTERISTICS, CONTAINING ESOMEPRAZOLE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF | 0 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.